quinazolines has been researched along with tiacrilast in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozóky, B; Csatò, M; Czarnetzki, BM; Judák, R | 1 |
| Befus, AD; Bienenstock, J; Lee, TD; Shanahan, F | 1 |
| Dunton, AW; McGhee, B; Welton, AF | 1 |
| Dunton, A; Keigher, N; Massarella, JW; Pao, J; Silvestri, TM | 1 |
| Baruth, H; Crowley, HJ; Hope, WC; Miller, DA; O'Donnell, M; Welton, AF; Yaremko, B | 1 |
| Baudin, M; Christophers, E; Dupuy, P; Goos, M; van de Kerkhof, PC | 1 |
| Baudin, M; Braun-Falco, O; Brechtel, B; Christophers, E; Czarnetzki, BM; Dupuy, P; Reckers-Czaschka, R; Schöpf, E | 1 |
| Algermissen, B; Bavandi, A; Fischer, E; Handjiski, B; Maurer, M; Paus, R; von Stebut, E | 1 |
3 trial(s) available for quinazolines and tiacrilast
| Article | Year |
|---|---|
The pharmacological profile and initial clinical evaluation of tiacrilast (Ro 22-3747): a new antiallergic agent.
Topics: Animals; Asthma; Bronchi; Clinical Trials as Topic; Cromolyn Sodium; Histamine H1 Antagonists; Histamine Release; Humans; Mast Cells; Passive Cutaneous Anaphylaxis; Quinazolines; Rats | 1986 |
Inhibitor of the release of mast cell mediators does not improve the psoriatic plaque.
Topics: Adult; Cell Degranulation; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Mast Cells; Middle Aged; Psoriasis; Quinazolines | 1995 |
Topical tiacrilast, a potent mast cell degranulation inhibitor, does not improve adult atopic eczema.
Topics: Administration, Cutaneous; Adult; Cell Degranulation; Dermatitis, Atopic; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Mast Cells; Quinazolines; Treatment Outcome | 1993 |
5 other study(ies) available for quinazolines and tiacrilast
| Article | Year |
|---|---|
Effect of tiacrilast, a mast cell mediator-release inhibitor, on murine experimental contact dermatitis.
Topics: Animals; Croton Oil; Dermatitis, Contact; Dimethyl Sulfoxide; Dinitrofluorobenzene; Female; Histamine H1 Antagonists; Mice; Quinazolines | 1990 |
Mast cell heterogeneity: effect of anti-allergic compounds on neuropeptide-induced histamine release.
Topics: Animals; Cromolyn Sodium; Dose-Response Relationship, Drug; Histamine Release; Hypersensitivity; Intestinal Mucosa; Male; Mast Cells; Nerve Tissue Proteins; Peritoneal Cavity; Quinazolines; Rats; Rats, Inbred Strains; Theophylline; Thioxanthenes; Xanthones | 1986 |
Pharmacokinetics of single and multiple ascending doses of the antiallergic agent tiacrilast in man.
Topics: Adult; Biological Availability; Dose-Response Relationship, Drug; Fasting; Food; Half-Life; Humans; Kinetics; Quinazolines | 1987 |
Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Topics: Aerosols; Anaphylaxis; Animals; Cromolyn Sodium; Drug Evaluation, Preclinical; Guinea Pigs; Histamine Release; Hypersensitivity, Immediate; Ileum; In Vitro Techniques; Lung; Male; Passive Cutaneous Anaphylaxis; Quinazolines; Rats; Rats, Inbred Strains; SRS-A; Thromboxane B2 | 1984 |
Activated skin mast cells are involved in murine hair follicle regression (catagen).
Topics: Adrenocorticotropic Hormone; Animals; Cromolyn Sodium; Dose-Response Relationship, Drug; Female; Hair Follicle; Immunohistochemistry; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron; Quinazolines; Skin Physiological Phenomena; Substance P | 1997 |